Announcement • Jul 20
Laiqon AG, Annual General Meeting, Aug 27, 2026 Laiqon AG, Annual General Meeting, Aug 27, 2026, at 11:00 W. Europe Standard Time. Price Target Changed • Jun 08
Price target decreased by 8.7% to €8.70 Down from €9.53, the current price target is an average from 3 analysts. New target price is 95% above last closing price of €4.47. Stock is up 25% over the past year. The company is forecast to post a net loss per share of €0.29 next year compared to a net loss per share of €0.93 last year. Announcement • Nov 22
LAIQON AG Partners with Amundi to Launch Active AI ETF for Europe in 2026 LAIQON AG announced that first active AI ETF will mark the start of a new LAIQON product family. The LAIQON Group is currently working on launching its first actively managed AI ETF in partnership with Amundi, using Amundi's ETF-as-a-Service platform. The new actively managed AI-optimized ETF will be designed to offer institutional and private investors innovative access to the growth potential of European stock markets, leveraging the proven AI technology of LAIC ADVISOR, which has been in use since 2019. LAIC ADVISOR employs a six-step, data-driven analysis and control process that combines global data sources, deep learning and factor models, and uses neural networks. This new ETF will aim to achieve long-term risk-adjusted outperformance relative to the European equity markets through the alpha potential of AI-supported portfolio management. The launch of the ETF is expected for first half of 2026, subject to regulatory approval. The ambition is to distribute the ETF in Germany and make it tradable on the usual platforms on each trading day from the start of distribution. The ETF marks the start of a planned product family, which is aimed at expanding in the future with further strategies, e.g., focusing on the US and global stock markets. As part of the partnership, the LAIQON Group will contribute its expertise in AI-supported portfolio management through its WealthTech subsidiary LAIC, while Amundi will take over the management of the ETF on its White Label and Active ETF platform, contributing its extensive experience in ETF structuring. Capital flows are shifting, new transformative industries are emerging, ESG regulations are forcing investors to adopt clear sustainability strategies, and the use of AI is fundamentally changing the financial world. The new LAIQON ETF aims at combining these trends, making it a differentiating factor in any portfolio. It also serves a segment of the rapidly growing market for active ETFs that has been largely overlooked until now. Announcement • Nov 18
Laiqon AG Announces Executive Changes The Supervisory Board of LAIQON AG has appointed Mr. Axel Hörger to the Executive Board as Chief Strategy Officer (CSTRO) with effect from January 1, 2026. Since March 2025, the former CEO of UBS Deutschland AG has been serving as Senior Advisor to the Board. Mr. Hörger succeeds Stefan Mayerhofer, who will step down from his position as Chief Wealth Officer on December 31, 2025, as planned. Mayerhofer will continue to serve selected clients as a senior advisor at BV Bayerische Vermögen GmbH and manage the Mayerhofer Strategie AMI fund. The newly formed Executive Board team, with Dipl.-Ing. Achim Plate as Chief Executive Officer (CEO) and Axel Hörger, is committed to close collaboration and shared responsibility in driving LAIQON AG’s GROWTH 28 strategy. Mr. Plate as CEO of the LAIQON Group is still responsible for the Digital Wealth business segment as well as the areas of Finance, Legal, Compliance, People & Organization, Technology, and IR/PR. As CSTRO, Mr. Hörger will be responsible for the asset and wealth management business segments as well as group sales and sustainability. He has in-depth expertise in capital markets coupled with digital and quantitative understanding. Special emphasis will be placed on strengthening collaboration with national and international partner networks in the area of sales. His parallel leadership role in the Swiss subsidiary of the LAIQON Group underscores the growing importance of the DACH region for the Group. Axel Hörger brings many years of leadership experience at international asset and wealth managers and can draw on a broad network in the industry. Most recently, he was co-founder and chairman of AIB Acquisition Cooperation, a New York-based SPAC listed on Nasdaq. Previously, he was CEO of Petiole Asset Management AG (Switzerland), CEO of Lombard International Assurance in Europe, and from 2011 to 2015 CEO of UBS Deutschland AG and head of its Wealth Management. Before that, Mr. Hörger worked for 16 years at Goldman Sachs as Managing Director, most recently as Head of Institutional Sales for EMEA in Asset Management. To this day, he is active in various advisory boards, including Siemens and Atlantik-Brücke e.V. Announcement • Jul 21
Laiqon AG, Annual General Meeting, Aug 28, 2025 Laiqon AG, Annual General Meeting, Aug 28, 2025, at 10:00 W. Europe Standard Time. Price Target Changed • Sep 02
Price target decreased by 19% to €9.10 Down from €11.17, the current price target is an average from 3 analysts. New target price is 80% above last closing price of €5.06. Stock is down 33% over the past year. The company is forecast to post a net loss per share of €0.39 next year compared to a net loss per share of €0.70 last year. Announcement • Jul 30
meine Volksbank Raiffeisenbank eG signed a letter of intent to acquire 25% stake in Bv Bayerische Vermögen GmbH from Laiqon AG (XTRA:LQAG). meine Volksbank Raiffeisenbank eG signed a letter of intent to acquire 25% stake in Bv Bayerische Vermögen GmbH from Laiqon AG (XTRA:LQAG) on July 30, 2024. The purchase and transfer agreement for the acquisition of 25% of BV GmbH is scheduled to be concluded within the next three months. The financial details of the investment have been kept confidential. As part of the deepening of the partnership agreed in the LoI, the mVBRB is to acquire a 25% stake in BV GmbH from LAIQON AG after completion of the due diligence. A first partial step of 9.9% of this is to be carried out directly. In order to complete the further 15.1% to 25% in a second partial step, the completion of an owner control procedure by the Federal Financial Supervisory Authority (BaFin) is required beforehand. Announcement • Jul 22
Laiqon AG, Annual General Meeting, Aug 29, 2024 Laiqon AG, Annual General Meeting, Aug 29, 2024, at 10:00 W. Europe Standard Time. New Risk • May 23
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-€12m). Shareholders have been diluted in the past year (5.4% increase in shares outstanding). Price Target Changed • Apr 19
Price target decreased by 8.2% to €11.17 Down from €12.17, the current price target is an average from 3 analysts. New target price is 127% above last closing price of €4.91. Stock is down 37% over the past year. The company is forecast to post a net loss per share of €0.25 next year compared to a net loss per share of €0.70 last year. Reported Earnings • Apr 01
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: €0.70 loss per share (further deteriorated from €0.67 loss in FY 2022). Revenue: €30.7m (up 43% from FY 2022). Net loss: €12.3m (loss widened 21% from FY 2022). Revenue missed analyst estimates by 8.6%. Earnings per share (EPS) also missed analyst estimates by 166%. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Capital Markets industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance. Price Target Changed • Jan 05
Price target increased by 9.5% to €12.35 Up from €11.28, the current price target is an average from 3 analysts. New target price is 90% above last closing price of €6.50. Stock is down 11% over the past year. The company is forecast to post a net loss per share of €0.26 next year compared to a net loss per share of €0.67 last year. New Risk • Nov 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Shareholders have been diluted in the past year (7.3% increase in shares outstanding). Price Target Changed • Jun 02
Price target increased by 8.0% to €11.82 Up from €10.94, the current price target is an average from 3 analysts. New target price is 52% above last closing price of €7.78. Stock is down 22% over the past year. The company is forecast to post a net loss per share of €0.26 next year compared to a net loss per share of €0.67 last year. Price Target Changed • Apr 06
Price target increased by 15% to €10.31 Up from €8.93, the current price target is an average from 4 analysts. New target price is 25% above last closing price of €8.22. Stock is down 16% over the past year. The company is forecast to post a net loss per share of €0.34 next year compared to a net loss per share of €0.67 last year. Reported Earnings • Apr 02
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: €0.67 loss per share (down from €0.39 profit in FY 2021). Revenue: €21.6m (down 17% from FY 2021). Net loss: €10.2m (down 297% from profit in FY 2021). Revenue missed analyst estimates by 25%. Earnings per share (EPS) also missed analyst estimates by 69%. Revenue is forecast to grow 25% p.a. on average during the next 3 years, while revenues in the Capital Markets industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 42% per year, which means it is well ahead of earnings. Price Target Changed • Feb 21
Price target decreased by 14% to €10.18 Down from €11.88, the current price target is an average from 4 analysts. New target price is 24% above last closing price of €8.20. Stock is down 25% over the past year. The company is forecast to post a net loss per share of €0.40 compared to earnings per share of €0.39 last year. Price Target Changed • Nov 16
Price target decreased to €11.65 Down from €12.80, the current price target is an average from 4 analysts. New target price is 65% above last closing price of €7.04. Stock is down 32% over the past year. The company is forecast to post a net loss per share of €0.48 compared to earnings per share of €0.39 last year. Price Target Changed • Oct 17
Price target decreased to €11.65 Down from €12.80, the current price target is an average from 3 analysts. New target price is 114% above last closing price of €5.44. Stock is down 43% over the past year. The company is forecast to post a net loss per share of €0.51 compared to earnings per share of €0.39 last year. Price Target Changed • Jul 29
Price target decreased to €12.80 Down from €17.17, the current price target is an average from 3 analysts. New target price is 76% above last closing price of €7.28. Stock is down 18% over the past year. The company posted earnings per share of €0.39 last year. Valuation Update With 7 Day Price Move • Jun 25
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €7.36, the stock trades at a forward P/E ratio of 79x. Average forward P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 41% over the past three years. Valuation Update With 7 Day Price Move • May 31
Investor sentiment improved over the past week After last week's 26% share price gain to €9.56, the stock trades at a forward P/E ratio of 71x. Average forward P/E is 14x in the Capital Markets industry in Germany. Total returns to shareholders of 90% over the past three years. Reported Earnings • Apr 03
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: €0.39 (up from €0.053 loss in FY 2020). Revenue: €26.1m (down 5.8% from FY 2020). Net income: €5.15m (up €5.85m from FY 2020). Profit margin: 20% (up from net loss in FY 2020). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 100%. Earnings per share (EPS) also missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 100% compared to a 7.4% decline forecast for the funds industry in Germany. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Feb 22
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €10.00, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 99% over the past three years. Valuation Update With 7 Day Price Move • Jan 31
Investor sentiment improved over the past week After last week's 21% share price gain to €13.05, the stock trades at a forward P/E ratio of 45x. Average forward P/E is 12x in the Capital Markets industry in Germany. Total returns to shareholders of 173% over the past three years. Valuation Update With 7 Day Price Move • Dec 28
Investor sentiment improved over the past week After last week's 17% share price gain to €16.70, the stock trades at a forward P/E ratio of 70x. Average forward P/E is 13x in the Capital Markets industry in Germany. Total returns to shareholders of 262% over the past three years. Price Target Changed • Sep 16
Price target increased to €14.47 Up from €12.68, the current price target is an average from 3 analysts. New target price is 47% above last closing price of €9.82. Stock is up 110% over the past year. Reported Earnings • Aug 29
First half 2021 earnings released: EPS €0.28 (vs €0.30 loss in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €18.2m (up 195% from 1H 2020). Net income: €3.71m (up €7.64m from 1H 2020). Profit margin: 20% (up from net loss in 1H 2020). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Price Target Changed • Jul 07
Price target increased to €12.68 Up from €11.45, the current price target is an average from 4 analysts. New target price is 26% above last closing price of €10.05. Stock is up 169% over the past year. Reported Earnings • Apr 04
Full year 2020 earnings released: €0.05 loss per share (vs €0.009 loss in FY 2019) The company reported a decent full year result with improved revenues, although losses increased and control over costs was weaker. Full year 2020 results: Revenue: €27.7m (up 237% from FY 2019). Net loss: €703.0k (loss widened €610.0k from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance. Price Target Changed • Jan 07
Price target raised to €9.75 Up from €8.45, the current price target is an average from 4 analysts. The new target price is 40% above the current share price of €6.95. As of last close, the stock is up 32% over the past year. Is New 90 Day High Low • Jan 06
New 90-day high: €6.90 The company is up 39% from its price of €4.96 on 08 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 5.0% over the same period. Price Target Changed • Nov 17
Price target raised to €7.58 Up from €6.88, the current price target is an average from 4 analysts. The new target price is 24% above the current share price of €6.10. As of last close, the stock is up 22% over the past year. Is New 90 Day High Low • Nov 05
New 90-day high: €6.00 The company is up 32% from its price of €4.54 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is per share. Is New 90 Day High Low • Oct 06
New 90-day high: €5.20 The company is up 39% from its price of €3.74 on 08 July 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is per share.